Srividya Ramakrishnan

Title: Innovations of Srividya Ramakrishnan

Introduction

Srividya Ramakrishnan is a notable inventor based in Princeton, NJ, who has made significant contributions to the field of pharmaceutical sciences. With a total of four patents to his name, he has focused on developing innovative solutions for treating diseases such as diabetes.

Latest Patents

Among his latest patents are the crystal structures of SGLT2 inhibitors and the processes for preparing these compounds. The inventions relate to the physical crystal structures of a compound of a specific formula, which includes pharmaceutical compositions containing these structures. The methods outlined in his patents also detail processes for preparing the compounds and intermediates used in their synthesis, ultimately aimed at treating diseases like diabetes.

Career Highlights

Throughout his career, Srividya has worked with prominent companies in the pharmaceutical industry, including Bristol-Myers Squibb Company and AstraZeneca AB. His work in these organizations has allowed him to contribute to groundbreaking research and development in drug formulation and delivery.

Collaborations

Srividya has collaborated with esteemed colleagues such as Jack Z Gougoutas and Hildegard Lobinger, who is a woman. These collaborations have further enriched his research and innovation efforts in the pharmaceutical domain.

Conclusion

In summary, Srividya Ramakrishnan is a distinguished inventor whose work in developing SGLT2 inhibitors has the potential to significantly impact diabetes treatment. His contributions to the field are marked by his innovative patents and collaborations with leading professionals in the industry.